Tobira Therapeutics, Inc.
Tobira Therapeutics, Inc. (TBRA) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 58 transactions totaling $92.3M, demonstrating a bullish sentiment with $76.0M in net insider flow. The most recent transaction on Nov 1, 2016 involved a transaction of 11 shares valued at $0.
TBRA Insider Activity Summary
Who Is Buying TBRA Stock?
No significant insider buying has been recorded for TBRA in the recent period.
Who Is Selling TBRA Stock?
No significant insider selling has been recorded for TBRA in the recent period.
Is Tobira Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TBRA is bullish with an Insider Alignment Score of 91/100 and a net flow of $76.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
TBRA Frequently Asked Questions
Understanding TBRA Insider Activity
Insider trading at Tobira Therapeutics, Inc. (TBRA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading TBRA stock, having executed 58 transactions in the past 90 days. The most active insider is Brian H. Dovey (Executive), who has made 1 transactions totaling $100.7M.
Related Tools
Track Tobira Therapeutics, Inc. Insider Activity
Get notified when executives and directors at TBRA file new Form 4 transactions